Development of a multi-antigenic SARS-CoV-2 vaccine candidate using a synthetic poxvirus platform.
Nat Commun. 2020 Nov 30;11(1):6121. doi: 10.1038/s41467-020-19819-1.
Nat Commun. 2020.
PMID: 33257686
Free PMC article.